ASBP
Aspire Biopharma Holdings
$6.97
−$0.29 (−3.99%)Jul 27, 2026
Key metrics
The numbers that frame ASBP today
- Market cap
- $9.03M
- P/E (TTM)
- -0.8
- EV / FCF
- -0.8
- Gross margin
- 16.3%
- EV / Sales
- 135.1
- ROIC
- 89.7%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $3.31
- 52wk High
- $1,050.36
Growth
Revenue and earnings trend for ASBP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ASBP
Is Aspire Biopharma Holdings a good buy?
No. Aspire Biopharma Holdings has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aspire Biopharma Holdings is selling at a very high price.
What is the market capitalization of ASBP?
Aspire Biopharma Holdings's market capitalization is $9.03M.
What is the P/E ratio for ASBP stock?
Aspire Biopharma Holdings's current P/E ratio is -0.8.
What is the 52-week high for ASBP stock?
The 52-week high for Aspire Biopharma Holdings is $1,050.36. The current close of $6.97 is 99.3% below that high.
What is the 52-week low for ASBP stock?
The 52-week low for Aspire Biopharma Holdings is $3.31. The current close of $6.97 is 110.6% above that low.
Does ASBP stock pay dividends?
Aspire Biopharma Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ASBP?
Aspire Biopharma Holdings's Debt / Equity ratio is 0.39.